ArticleFrontiers in oncology2020

Case Report: Primary and Acquired Resistance Mechanisms of Nimotuzumab in Advanced Esophageal Squamous Cell Carcinoma Revealed by Targeted Sequencing.

Dantong Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.